Seth E. Karol

2.3k citations

73 papers · 635 indexed · h-index 13

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Public Health, Environmental and Occupational Health top 10%
- Acute Lymphoblastic Leukemia research

Papers in ⓘ

Hematology 39
- Acute Myeloid Leukemia Research 29
- Chronic Myeloid Leukemia Treatments 8
Public Health, Environmental and Occupational Health 38
- Acute Lymphoblastic Leukemia research 38

Co-authors: Ching‐Hon Pui (37 shared papers)Mary V. Relling (26 shared papers)Sima Jeha (23 shared papers)Hiroto Inaba (26 shared papers)William E. Evans (11 shared papers)Wenjian Yang (14 shared papers)Jeffrey E. Rubnitz (21 shared papers)Kristine R. Crews (9 shared papers)
Journals: Blood (15 papers)Pediatric Blood & Cancer (8 papers)Haematologica (5 papers)Clinical Pharmacology & Therapeutics (5 papers)Cancer (4 papers)
Partner nations: United States Germany France

In The Last Decade

Seth E. Karol

61 papers receiving 630 citations

Peers

Countries citing papers authored by Seth E. Karol

Since Specialization

Citations

This map shows the geographic impact of Seth E. Karol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth E. Karol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth E. Karol more than expected).

Fields of papers citing papers by Seth E. Karol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth E. Karol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth E. Karol. The network helps show where Seth E. Karol may publish in the future.

Co-authors

The 25 scholars most cited alongside Seth E. Karol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Seth E. Karol Line = papers co-authored together Seth E. Karol links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study The Lancet Oncology ·Seth E. Karol, Thomas Alexander, Amit Budhraja, Stanley Pounds, Kristin Canavera, Lei Wang, Joshua Wolf, Jeffery M. Klco, Paul E. Mead, Soumyasri Das Gupta, Su Y. Kim, Ahmed Hamed Salem, Tammy L. Palenski, Norman J. Lacayo, Ching‐Hon Pui, Joseph T. Opferman, Jeffrey E. Rubnitz	2020	96
2	Antibodies Predict Pegaspargase Allergic Reactions and Failure of Rechallenge Journal of Clinical Oncology ·Yiwei Liu, Colton A. Smith, John C. Panetta, Wenjian Yang, Lauren Thompson, Jacob Counts, Alejandro R. Molinelli, Deqing Pei, Nancy M. Kornegay, Kristine R. Crews, Hope D. Swanson, Cheng Cheng, Seth E. Karol, William E. Evans, Hiroto Inaba, Ching‐Hon Pui, Sima Jeha, Mary V. Relling	2019	64
3	Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia Pediatric Blood & Cancer ·Emily R. Finch, Colton A. Smith, Wenjian Yang, Yiwei Liu, Nancy M. Kornegay, John C. Panetta, Kristine R. Crews, Alejandro R. Molinelli, Cheng Cheng, Deqing Pei, Laura B. Ramsey, Seth E. Karol, Hiroto Inaba, John T. Sandlund, Monika L. Metzger, William E. Evans, Sima Jeha, Ching‐Hon Pui, Mary V. Relling	2019	41
4	Comparison of genome sequencing and clinical genotyping for pharmacogenes Clinical Pharmacology & Therapeutics ·Wenjian Yang, Gang Wu, Ulrich Broeckel, CA Smith, Victoria Turner, Cyrine E. Haidar, S Wang, Richard Carter, Seth E. Karol, Geoffrey Neale, Kristine R. Crews, JJ Yang, CG Mullighan, JR Downing, Evans We, MV Relling	2016	37
5	Elevated CAIX Expression is Associated with an Increased Risk of Distant Failure in Early-Stage Cervical Cancer Biomarker Insights ·John P. Kirkpatrick, Zahid N. Rabbani, Rex C. Bentley, Matt E. Hardee, Seth E. Karol, Jeffrey Meyer, Egbert Oosterwijk, Laura J. Havrilesky, Angeles Alvarez Secord, Željko Vujašković, Mark W. Dewhirst, Ellen L. Jones	2008	27
6	Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy British Journal of Haematology ·Seth E. Karol, Elaine Coustan‐Smith, Xueyuan Cao, Sheila Shurtleff, Susana C. Raimondi, John Choi, Raul C. Ribeiro, Gary V. Dahl, W. Paul Bowman, Jeffrey W. Taub, Barbara Degar, Wing Leung, James R. Downing, Ching‐Hon Pui, Jeffrey E. Rubnitz, Dario Campana, Hiroto Inaba	2014	24
7	Diabetes mellitus among adult survivors of childhood acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort Study Cancer ·Hannah Williams, Carrie R. Howell, Wassim Chemaitilly, Carmen L. Wilson, Seth E. Karol, Val Nolan, Matthew P. Smeltzer, Daniel M. Green, Matthew J. Ehrhardt, Daniel A. Mulrooney, Ching‐Hon Pui, Melissa M. Hudson, Leslie L. Robison, Kirsten K. Ness	2019	19
8	Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemia Cancer ·Seth E. Karol, Todd M. Cooper, Paul E. Mead, Kristine R. Crews, John C. Panetta, Thomas Alexander, Jeffrey W. Taub, Norman J. Lacayo, Kenneth Heym, Dennis John Kuo, Deborah Schiff, Deepa Bhojwani, Yubin Ge, Jeffery M. Klco, Raul C. Ribeiro, Hiroto Inaba, Ching‐Hon Pui, Jeffrey E. Rubnitz	2020	17
9	Genetics of pleiotropic effects of dexamethasone Pharmacogenetics and Genomics ·Laura B. Ramsey, Stanley Pounds, Cheng Cheng, Xueyuan Cao, Wenjian Yang, Colton Smith, Seth E. Karol, Chengcheng Liu, John C. Panetta, Hiroto Inaba, Jeffrey E. Rubnitz, Monika L. Metzger, Raul C. Ribeiro, John T. Sandlund, Sima Jeha, Ching‐Hon Pui, William E. Evans, Mary V. Relling	2017	16
10	Effect of Premedications in a Murine Model of Asparaginase Hypersensitivity Journal of Pharmacology and Experimental Therapeutics ·Christian A. Fernandez, Colton Smith, Seth E. Karol, Laura B. Ramsey, Chengcheng Liu, Ching‐Hon Pui, Sima Jeha, William E. Evans, Fred D. Finkelman, Mary V. Relling	2015	16
11	Infectious Complications in Pediatric, Adolescent and Young Adult Patients Undergoing CD19-CAR T Cell Therapy Frontiers in Oncology ·Gabriela Marón, Diego R. Hijano, Rebecca Epperly, Yin Su, Li Tang, Randall T. Hayden, Swati Naik, Seth E. Karol, Stephen Gottschalk, Brandon M. Triplett, Aimee C. Talleur	2022	15
12	Personalized therapy in pediatric high-risk B-cell acute lymphoblastic leukemia Therapeutic Advances in Hematology ·Seth E. Karol, Ching‐Hon Pui	2020	14
13	Palmar‐plantar erythrodysesthesia syndrome following treatment with high‐dose methotrexate or high‐dose cytarabine Cancer ·Seth E. Karol, Wenjian Yang, Colton Smith, Cheng Cheng, Clinton F. Stewart, Sharyn D. Baker, John T. Sandlund, Jeffrey E. Rubnitz, Michael W. Bishop, Alberto S. Pappo, Sima Jeha, Ching‐Hon Pui, Mary V. Relling	2017	13
14	Safety, Efficacy, and PK of the BCL2 Inhibitor Venetoclax in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Phase 1 Study Blood ·Seth E. Karol, Todd M. Cooper, Henrique Bittencourt, Lia Gore, Maureen M. O’Brien, Christopher Fraser, Marion Gambart, Gunnar Cario, C. Michel Zwaan, Jean‐Pierre Bourquin, Mignon L. Loh, Hubert Caron, Betty Prine, Ahmed Hamed Salem, Kristina Unnebrink, Bo Tong, Tammy L. Palenski, Andrew E. Place	2019	12
15	Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia JAMA Network Open ·Wenjian Yang, Seth E. Karol, Keito Hoshitsuki, Shawn Lee, Eric Larsen, Naomi Winick, William L. Carroll, Mignon L. Loh, Elizabeth A. Raetz, Stephen P. Hunger, Stuart S. Winter, Kimberly P. Dunsmore, Meenakshi Devidas, Mary V. Relling, Jun J. Yang	2022	12
16	Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia Cancer Medicine ·Seth E. Karol, Yilun Sun, Li Tang, Ching‐Hon Pui, Jose Ferrolino, Kim Allison, Shane J. Cross, William E. Evans, Kristine R. Crews, Sima Jeha, Joshua Wolf	2020	12
17	Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia PLoS ONE ·Laura B. Ramsey, Laura J. Janke, Monique A. Payton, Xiangjun Cai, Steven W. Paugh, Seth E. Karol, Landry K. Kamdem, Cheng Cheng, Richard T. Williams, Sima Jeha, Ching‐Hon Pui, William E. Evans, Mary V. Relling	2015	11
18	Long-Term Functional Outcomes Among Childhood Survivors of Cancer Who Have a History of Osteonecrosis Physical Therapy ·Brian DeFeo, Sue C. Kaste, Zhenghong Li, Tara M. Brinkman, Michael D. Neel, Deo Kumar Srivastava, Melissa M. Hudson, Leslie L. Robison, Seth E. Karol, Kirsten K. Ness	2019	11
19	Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid‐induced osteonecrosis Pediatric Blood & Cancer ·Emily R. Finch, Laura J. Janke, Colton A. Smith, Seth E. Karol, Deqing Pei, Cheng Cheng, Sue C. Kaste, Hiroto Inaba, Ching‐Hon Pui, Joshua Wolf, Mary V. Relling	2019	9
20	Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase Hypersensitivity Clinical Pharmacology & Therapeutics ·Yi-Wei Liu, Wenjian Yang, Colton A. Smith, Cheng Cheng, Seth E. Karol, Eric Larsen, Naomi Winick, William L. Carroll, Mignon L. Loh, Elizabeth A. Raetz, Stephen P. Hunger, Stuart S. Winter, Kimberly P. Dunsmore, Meenakshi Devidas, Jun J. Yang, William E. Evans, Sima Jeha, Ching‐Hon Pui, Hiroto Inaba, Mary V. Relling	2021	9

About Seth E. Karol

Seth E. Karol is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Orthopedics and Sports Medicine and Oncology, having authored 73 papers that have together received 635 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (38 papers), Acute Myeloid Leukemia Research (29 papers), Childhood Cancer Survivors' Quality of Life (22 papers), Bone and Joint Diseases (11 papers), Chronic Myeloid Leukemia Treatments (8 papers), Neutropenia and Cancer Infections (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Hematology (222 citations), Public Health, Environmental and Occupational Health (255 citations), Pediatrics, Perinatology and Child Health (167 citations), Oncology (152 citations) and Orthopedics and Sports Medicine (48 citations). Seth E. Karol has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Ching‐Hon Pui, Mary V. Relling, Sima Jeha, Hiroto Inaba, William E. Evans, Wenjian Yang, Jeffrey E. Rubnitz, Kristine R. Crews, Cheng Cheng and John C. Panetta. Their work appears in journals such as Blood, Pediatric Blood & Cancer, Haematologica, Clinical Pharmacology & Therapeutics and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact